Litcius/Paper detail

Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies

Iosif Papafragkos, Efrosyni Markaki, Christina Kalpadakis, Panayotis Verginis

2021Journal of Clinical Medicine17 citationsDOIOpen Access PDF

Abstract

Myeloid-derived suppressor cells (MDSCs) are immature myeloid precursors which emerged as a potent regulator of the immune system, exerting suppressive properties in diverse disease settings. In regards to cancer, MDSCs have an established role in solid tumors; however, their contribution to immune regulation during hematologic malignancies and particularly in lymphomas remains ill-defined. Herein focused on lymphoma, we discuss the literature on MDSC cells in all histologic types, and we also refer to lessons learned by animal models of lymphoma. Furthermore, we elaborate on future directions and unmet needs and challenges in the MDSC field related to lymphoma malignancies which may shed light on the complex nature of the immune system in malignancies.

Topics & Concepts

MedicineLymphomaImmune systemMyeloid-derived Suppressor CellMyeloidSuppressorRegulatorCancer researchImmunologyDiseaseCancerPathologyGeneBiologyInternal medicineGeneticsImmune cells in cancerImmune Cell Function and InteractionEpigenetics and DNA Methylation
Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies | Litcius